+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Update on inhalational anaesthetics

Update on inhalational anaesthetics

Current Opinion in Anaesthesiology 22(4): 491-495

Inhalational anaesthetic agents are a cornerstone in modern anaesthetic practice. The currently used compounds are very effective and have a good safety profile. In addition, it has been demonstrated that they possess organ-protective properties that might provide an additional tool in the treatment or prevention of the consequences of organ ischaemia-reperfusion injury or both. The present review summarizes some of the most recent findings on this subject. The mechanisms underlying the organ-protective effects of inhalational anaesthetics continue to be further unravelled. The main challenge, however, is to determine the clinical importance of these protective effects and their potential benefits for patients. Initial observations in cardiac surgery are encouraging, and the first clinical studies on other organ systems are being published. Noble gases share these organ-protective properties and may provide an additional tool for this purpose both in situations in which anaesthesia is needed (xenon) or in cases in which anaesthesia is not necessary (helium). In the experimental setting, inhalational anaesthetics have protective effects against ischaemia-reperfusion injury. Initial perioperative data suggest that these effects may also result into clinically relevant improved organ function. However, further research will be needed to reveal whether these organ-protective properties will ultimately translate into an improved short-term and long-term postoperative outcome.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056776152

Download citation: RISBibTeXText

PMID: 19369864

DOI: 10.1097/aco.0b013e32832bca38

Related references

Inhalational anaesthetics: an update. Acta Anaesthesiologica Belgica 47(1): 3-6, 1996

Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Practice and Research. Clinical Anaesthesiology 19(3): 523-538, 2005

New inhalational anaesthetics. Anaesthesist 45(8): 674-693, 1996

Inhalational anaesthetics. 2012

Inhalational anaesthetics and cardioprotection. Handbook of Experimental Pharmacology 2008(182): 187-207, 2008

Halogenated inhalational anaesthetics. Best Practice and Research. Clinical Anaesthesiology 17(1): 29-46, 2003

Pharmacokinetics of Inhalational Anaesthetics. Lancet 2(7351): 143-145, 1964

The newer inhalational anaesthetics. Practitioner 161(965): 361-371, 1948

Drug interactions with inhalational anaesthetics. Acta Anaesthesiologica Scandinavica 37(3): 231-244, 1993

Chronic toxicity of inhalational anaesthetics. Annals of the Royal College of Surgeons of England 48(2): 79-79, 1971

Occupational exposure to inhalational anaesthetics. Anaesthesia 52(7): 714, 1997

Mechanisms of action of inhalational anaesthetics. South African Journal of Medical Sciences 41(4): 305-326, 1976

Interaction of inhalational anaesthetics with CO2 absorbents. Best Practice and Research. Clinical Anaesthesiology 17(1): 63-76, 2003

Biotransformation and toxicity of inhalational anaesthetics. Canadian Journal of Anaesthesia 37(4 Pt 2): Scxvi-Scxxiii, 1990

Occupational hazards of inhalational anaesthetics. Best Practice and Research. Clinical Anaesthesiology 17(1): 147-161, 2003